Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.
Frequently asked questions
What sector does Lukas Biomedical Inc. (6814) operate in?
Lukas Biomedical Inc. belongs to the Other sector and operates in the Biotechnology industry.
What is Lukas Biomedical Inc. (6814) current stock price?
As of the latest data, Lukas Biomedical Inc. stock price is NT$22.10, with a previous close of NT$23.00. Lukas Biomedical Inc. lost -NT$0.90 in the last trading session, representing a -3.91% loss.
What is Lukas Biomedical Inc. (6814) current market capitalization?
Lukas Biomedical Inc. market cap is approximately 925.42 million.
What is Lukas Biomedical Inc. (6814) Earnings Per Share (EPS)?
The trailing EPS is -NT$2.05.
Does Lukas Biomedical Inc. (6814) pay dividends?
No. Lukas Biomedical Inc. does not pay a dividend.
What is Lukas Biomedical Inc. (6814) beta (volatility) score?
Lukas Biomedical Inc. has a beta of 0.129, indicating lower volatility than the overall market.
